FORM 8.3 - AON PLC - AMENDMENT

FORM 8.3 - AON PLC - AMENDMENT

BARCLAYS PLC

 

FORM 8.3

Amendment to sales

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in AON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 30 March 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

457,403

0.20%

1,735,006

0.77%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

96,538

0.04%

13,657

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

24,200

0.01%

24,200

0.01%

 

 

 

 

(4)

TOTAL:

 

 

 

 

578,141

0.26%

1,772,863

0.78%

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

3

233.4300 USD
Purchase

4

233.8800 USD
Purchase

6

231.9650 USD
Purchase

12

232.2800 USD
Purchase

50

233.5200 USD
Purchase

54

233.3500 USD
Purchase

100

233.3600 USD
Purchase

100

232.9000 USD
Purchase

106

233.5122 USD
Purchase

125

233.3700 USD
Purchase

200

232.1700 USD
Purchase

200

232.6950 USD
Purchase

226

233.4019 USD
Purchase

312

233.3800 USD
Purchase

406

232.1439 USD
Purchase

411

232.6200 USD
Purchase

427

232.6594 USD
Purchase

441

232.3719 USD
Purchase

809

232.3186 USD
Purchase

814

232.8074 USD
Purchase

1,814

232.1036 USD
Purchase

2,888

232.0900 USD
Purchase

3,030

232.3960 USD
Purchase

5,113

232.5124 USD
Purchase

5,985

232.3971 USD
Purchase

11,356

232.4862 USD
Purchase

18,996

232.3802 USD
Purchase

21,114

232.0382 USD
Sale

1

232.6100 USD
Sale

1

232.4800 USD
Sale

1

233.0500 USD
Sale

1

232.4000 USD
Sale

2

232.4550 USD
Sale

2

232.9750 USD
Sale

3

232.0200 USD
Sale

4

231.9650 USD
Sale

4

232.2750 USD
Sale

5

232.6850 USD
Sale

8

233.8800 USD
Sale

10

232.8300 USD
Sale

12

232.8700 USD
Sale

18

232.6183 USD
Sale

35

232.6048 USD
Sale

58

232.8100 USD
Sale

100

232.6200 USD
Sale

100

232.1100 USD
Sale

100

232.8800 USD
Sale

100

232.4100 USD
Sale

100

232.3300 USD
Sale

100

232.1200 USD
Sale

105

232.5800 USD
Sale

106

232.2070 USD
Sale

110

231.5286 USD
Sale

200

231.9050 USD
Sale

224

232.4994 USD
Sale

248

232.1138 USD
Sale

252

232.1260 USD
Sale

290

232.1231 USD
Sale

300

231.7533 USD
Sale

400

232.1250 USD
Sale

470

232.1755 USD
Sale

500

232.5360 USD
Sale

500

231.8090 USD
Sale

528

232.3666 USD
Sale

635

232.2908 USD
Sale

650

232.2661 USD
Sale

696

231.9944 USD
Sale

700

232.0400 USD
Sale

872

232.0410 USD
Sale

1,000

232.1570 USD
Sale

1,000

232.1130 USD
Sale

1,112

232.6278 USD
Sale

1,410

232.1547 USD
Sale

1,417

233.0812 USD
Sale

2,016

232.3154 USD
Sale

2,088

232.3933 USD
Sale

2,808

232.0793 USD
Sale

3,097

232.3934 USD
Sale

3,857

231.8977 USD
Sale

5,072

232.1900 USD
Sale

5,472

232.3860 USD
Sale

5,555

232.0183 USD
Sale

5,783

232.5674 USD
Sale

5,963

232.0900 USD
Sale

22,375

232.4652 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 1 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative

relates

 

 

 

Put Options Purchased

-1,200

220.0000

American

Jul 16, 2021

Call Options Purchased

1,200

240.0000

American

Jul 16, 2021

Call Options Purchased

23,000

220.0000

American

Jul 16, 2021

Put Options Purchased

-23,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

UK 100

Latest directors dealings